EUVIMEDOpdag EUVIMED
Open access

Transition of cellular senescence to pyroptosis mediates recurrence of small cell lung cancer after chemotherapy

Lie Ma iD, Yu Han iD, Zixin Chen iD, Xuan Liu iD, Yu Wang iD, Zhiyao Wang iD, Weifang Xiang iD, Lei Li iD, Xin Jin iD, Jingyao Hou iD, Yue Li iD, Baiqu Huang iD and 2 more

Science Advances · 2025

DOI: 10.1126/sciadv.adw1553 ↗

At a glance

Journal article in Science Advances, 2025. Written by Lie Ma and 13 co-authors. Institution: The Key Laboratory of Molecular Epigenetics of Ministry of Education (MOE), Northeast Normal University, Changchun 130024, China. Major MEDLINE topics: Pyroptosis, Cellular Senescence, Small Cell Lung Carcinoma, Lung Neoplasms. Cited 10 times so far (Crossref); 54 references. The full text is freely available in PubMed Central.

AbstractSubjectsBibliografiske oplysningerCiteRelated studies

Abstract (original language)

Chemotherapy-induced different cell fates play crucial roles in cancer treatment outcomes; however, the cross-talk between the cell fates during cancer recurrence remains unclear. Here, we found that the transition from cellular senescence to pyroptosis promoted small cell lung cancer (SCLC) recurrence after cisplatin and etoposide treatment. Parts of the senescent SCLC cells induced by chemotherapy showed positive cytoplasmic chromatin fragments (CCFs), and CCFs activated the ubiquitin-editing enzyme A20, which stabilized NLRP3 through its deubiquitinating activity, resulting in senescent cells undergoing pyroptosis. Subsequent inflammatory factors [such as interleukin-1 (IL-1)] released by pyroptosis promoted the acquisition of stem-like properties in CCF-negative senescent cells, ultimately promoting tumor recurrence. We also found that a combination of IL-1 receptor antagonist anakinra with chemotherapy delayed recurrence of SCLC, suggesting previously unidentified therapeutic strategies for SCLC.

Subjects

MeSH terms (MEDLINE)

PyroptosisCellular SenescenceSmall Cell Lung CarcinomaLung NeoplasmsNeoplasm Recurrence, LocalChromatinCisplatinEtoposideAntineoplastic Agents, PhytogenicInterleukin 1 Receptor Antagonist ProteinXenograft Model Antitumor AssaysMice, NudeMaleAnimalsMiceMice, Inbred BALB C

Substances

ChromatinCisplatinEtoposideAntineoplastic Agents, PhytogenicInterleukin 1 Receptor Antagonist Protein

Authors and institutions

  • The Key Laboratory of Molecular Epigenetics of Ministry of Education (MOE), Northeast Normal University, Changchun 130024, China.
  • School of life science, Northeast Normal University, Changchun 130024, China.
  • Medical Oncology Department, Affiliated Tumor Hospital, Harbin Medical University, Harbin 150001, China.

ORCID profiles: Lie Ma, Yu Han, Zixin Chen, Xuan Liu, Yu Wang, Zhiyao Wang, Weifang Xiang, Lei Li, Xin Jin, Jingyao Hou, Yue Li, Baiqu Huang, Jun Lu, Yu Zhang

Cite

APA

Ma, L., Han, Y., Chen, Z., Liu, X., Wang, Y., Wang, Z., Xiang, W., Li, L., Jin, X., Hou, J., Li, Y., Huang, B., Lu, J., & Zhang, Y. (2025). Transition of cellular senescence to pyroptosis mediates recurrence of small cell lung cancer after chemotherapy. Science Advances. https://doi.org/10.1126/sciadv.adw1553

Vancouver

Ma L, Han Y, Chen Z, Liu X, Wang Y, Wang Z, et al. Transition of cellular senescence to pyroptosis mediates recurrence of small cell lung cancer after chemotherapy. Science Advances. 2025. doi:10.1126/sciadv.adw1553

BibTeX
@article{Ma2025,
  author = {Ma, Lie and Han, Yu and Chen, Zixin and Liu, Xuan and Wang, Yu and Wang, Zhiyao and Xiang, Weifang and Li, Lei and Jin, Xin and Hou, Jingyao and Li, Yue and Huang, Baiqu and Lu, Jun and Zhang, Yu},
  title = {Transition of cellular senescence to pyroptosis mediates recurrence of small cell lung cancer after chemotherapy},
  journal = {Science Advances},
  year = {2025},
  doi = {10.1126/sciadv.adw1553}
}
Start for free →